Pfizer Revenue TTM:
57.60B for Dec. 31, 2012Pfizer Historical Revenue TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 57.60B |
| Dec. 31, 2012 | 59.51B |
| Sept. 30, 2012 | 60.58B |
| June 30, 2012 | 63.21B |
| March 31, 2012 | 64.64B |
| Dec. 31, 2011 | 65.74B |
| Sept. 30, 2011 | 65.06B |
| June 30, 2011 | 64.44B |
| March 31, 2011 | 65.09B |
| Dec. 31, 2010 | 65.16B |
| Sept. 30, 2010 | 66.24B |
| June 30, 2010 | 61.87B |
| March 31, 2010 | 55.72B |
| Dec. 31, 2009 | 50.01B |
| Sept. 30, 2009 | 45.82B |
| June 30, 2009 | 46.17B |
| March 31, 2009 | 47.32B |
| Dec. 31, 2008 | 48.30B |
| Sept. 30, 2008 | 48.82B |
| June 30, 2008 | 48.84B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenues (TTM)
PFE Revenue TTM Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | 68.59B |
| Merck | 46.21B |
| Bristol-Myers Squibb | 16.20B |
PFE Revenue TTM Rankings
| Overall |
99th percentile 75 of 7590 |
| Sector |
98th percentile 9 of 651 in Healthcare |
| Industry |
94th percentile 3 of 52 in Drug Manufacturers - Major |
PFE Revenue TTM Range, Past 5 Years
| Minimum | 45.82B | Sep 2009 |
| Maximum | 66.24B | Sep 2010 |
| Average | 57.51B |
